AMPH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Amphastar Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 21.91 USD 0.14%

Market Cap: $966m

	Amphastar Pharmaceuticals Inc NASDAQ:AMPH	US
	NeutriSci International Inc XTSX:NU	CA
	Bragg Gaming Group Inc TSX:BRAG	CA
	China Evergrande New Energy Vehicle Group Ltd HKEX:708	CN
N	Nebius Group NV XMUN:YDX	NL
	Marel hf AEX:MAREL	IS
	Battery Minerals Ltd ASX:BAT	AU
S	Service Corporation International XMUN:SVC	US
	Bewi ASA OSE:BEWI	NO
	OMV AG F:OMVI	AT
	Lechwerke AG F:LEC	DE
S	Simcorp A/S CSE:SIM	DK
E	EnSync Inc OTC:ESNC	US

Profitability Summary

Amphastar Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

48%

Strong 3Y Average Gross Margin

51%

Declining Gross Margin

51% > 48%

Healthy Operating Margin

16%

Sustainable 3Y Average Operating Margin

25%

Declining Operating Margin

24% > 16%

Healthy Net Margin

11%

Sustainable 3Y Average Net Margin

19%

Declining Net Margin

19% > 11%

Exceptional Free Cash Flow Margin

21%

Strong 3Y Average Free Cash Flow Margin

21%

Free Cash Flow Margin is Increasing

19% > 21%

Positive ROE

10%

Positive 3Y Average ROE

Positive 3Y Average ROIC

13%

Declining ROIC

12% > 6%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.